Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Nature Reviews. Cancer|November 26, 2009
Mucins in cancer: function, prognosis and therapyDonald W KufeJournal of Cancer Metastasis and Treatment|May 11, 2022
Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cellsDonald W KufeCancers|October 14, 2022
Emergence of MUC1 in Mammals for Adaptation of Barrier EpitheliaDonald W KufeBiochimica Et Biophysica Acta. Reviews on Cancer|February 1, 2026
Evolution of the MUC1 gene in eutherian mammals as an adaptation responsible for the increasing incidence of cancer in humansDonald W KufeCarcinogenesis|July 26, 2020
MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatmentDonald W KufeCancer Immunology, Immunotherapy : CII|March 17, 2004
Antitumor effects of fusions composed of dendritic cells and fibroblasts transfected with genomic DNA from tumor cellsMotoyuki Nakamura, Tetsuro Kikuchi, Donald W Kufe, et al.Oncotarget|November 8, 2017
CBP501 induces immunogenic tumor cell death and CD8 T cell infiltration into tumors in combination with platinum, and increases the efficacy of immune checkpoint inhibitors against tumors in miceKeiichi Sakakibara, Takuji Sato, Donald W Kufe, et al.Cancer Research|September 18, 2004
Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastomaBakhtiar Yamini, Xiaohong Yu, G Yancey Gillespie, et al.Molecular Cancer Therapeutics|July 24, 2014
Activation of Nrf2 pathways correlates with resistance of NSCLC cell lines to CBP501 in vitroNaoki Mine, Sayaka Yamamoto, Donald W Kufe, et al.Oncotarget|November 2, 2017
CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin bindingNaoya Saito, Naoki Mine, Donald W Kufe, et al.Pageof 4